Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.48 USD | -7.20% | +7.94% | +11.64% |
May. 17 | UBS Adjusts Price Target on GoodRx Holdings to $9 From $8, Maintains Neutral Rating | MT |
May. 17 | Deutsche Bank Adjusts GoodRx Price Target to $9 From $8, Maintains Hold Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.64% | 3.02B | |
+34.54% | 472B | |
+6.66% | 138B | |
+32.61% | 98.36B | |
+6.99% | 93.44B | |
+61.15% | 59.13B | |
+18.75% | 47.5B | |
+24.94% | 39.41B | |
+0.13% | 35.99B | |
+15.50% | 29.22B |
- Stock Market
- Equities
- GDRX Stock
- News GoodRx Holdings, Inc.
- GoodRx Q4 Adjusted Earnings, Revenue Gain; Sets Q1, 2024 Revenue Outlook; Approves $450 Million Share Buyback Plan